THE Therapeutic Goods Administration has published a notice on the current status of the Essure contraceptive device, which is the subject of a newly launched class action in Australia.
The TGA notes that Essure was cancelled from the Australian Register of Therapeutic Goods (ARTG) on 09 Feb 2018, but in addition no new Essure devices had been supplied for the Australian market after 31 May 2017.
Since 1999 Essure has been the subject of 59 adverse event reports.
The above article was sent to subscribers in Pharmacy Daily's issue from 15 Aug 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Aug 18
